Johan Eriksson is a licensed psychologist who worked as a therapist in Sweden’s first clinical trial of psilocybin treatment for depression at Karolinska Institute in Stockholm, sponsored by Osmond Labs. He has a background in Cognitive Behavioral Therapy, Acceptance and Commitment Therapy (ACT), and Intensive Short-term Dynamic Psychotherapy (ISTDP). He works with clients for psychedelic preparation and integration, as well as general psychotherapy in private practice. In 2016 Johan co-founded the Swedish Network for Psychedelic Science (NPV), and in 2019 he arranged and participated in the first Psychedelics 101 and 102 in Sweden (led by Fluence). Johan has also co-authored a peer-reviewed paper on ACT and psychedelic-assisted psychotherapy. In 2021 Johan co-founded Nysnö, where he is currently lead facilitator organizing retreat programs with psilocybin truffles in the Netherlands.
